I understand and agree with all of that and apologize for anything I said that may have led you to believe that I'm missing the point of this trial and that enrollees just show up sick after enrolling and participate at a clinical site.
"These are ER patients at hospitals who are then asked if they want to take an experimental drug for Covid-19."
Or ICU patients, right? Not necessarily ER patients who just showed up sick.
In any event, qualified enrollees are by definition already "sick" and hospitalized.
Per the Company"The Phase 2 randomized, placebo-controlled clinical trial is to include approximately 120 hospitalized patients with moderate-to-severe COVID-19."
"A hundred patients could fully enroll and complete treatment in a week. Completion of the trial would be a month later."
Indeed they could. By that math the Russian patients could have been treated and had their endpoints
determined already. Is that what you think?
News 
Market Data 
Discover 
